journal
https://read.qxmd.com/read/38624045/rna-m6a-modification-shaping-cutaneous-melanoma-tumor-microenvironment-and-predicting-immunotherapy-response
#1
JOURNAL ARTICLE
Yanhong Wu, Hongying He, Kairong Zheng, Zhenxin Qin, Naikun Cai, Shuguang Zuo, Xiao Zhu
Recent years have seen rising mortality rates linked to cutaneous melanoma (SKCM), despite advances in immunotherapy. Understanding RNA N6-methyladenosine (M6A) significance in SKCM is crucial for prognosis, tumor microenvironment (TME), immune cell presence, and immunotherapy efficacy. We analyzed 23 M6A regulators using SKCM samples from TCGA and GEO databases, identifying three M6A modification patterns linked to TME cell infiltration. Principal component analysis (PCA) yielded an M6A score for individual tumors, utilizing patient gene expression profiles and CNV data from TCGA...
April 16, 2024: Pigment Cell & Melanoma Research
https://read.qxmd.com/read/38613320/molecular-heterogeneity-of-quiescent-melanocyte-stem-cells-revealed-by-single-cell-rna-sequencing
#2
JOURNAL ARTICLE
Joseph W Palmer, Nilesh Kumar, Luye An, Andrew C White, M Shahid Mukhtar, Melissa L Harris
Melanocyte stem cells (McSCs) of the hair follicle are a rare cell population within the skin and are notably underrepresented in whole-skin, single-cell RNA sequencing (scRNA-seq) datasets. Using a cell enrichment strategy to isolate KIT+/CD45- cells from the telogen skin of adult female C57BL/6J mice, we evaluated the transcriptional landscape of quiescent McSCs (qMcSCs) at high resolution. Through this evaluation, we confirmed existing molecular signatures for qMcCS subpopulations (e.g., Kit+, Cd34+/-, Plp1+, Cd274+/-, Thy1+, Cdh3+/-) and identified novel qMcSC subpopulations, including two that differentially regulate their immune privilege status...
April 13, 2024: Pigment Cell & Melanoma Research
https://read.qxmd.com/read/38560773/2-mercaptonicotinoyl-glycine-a-new-potent-melanogenesis-inhibitor-exhibits-a-unique-mode-of-action-while-preserving-melanocyte-integrity
#3
JOURNAL ARTICLE
Peggy Sextius, Emilie Warrick, Amélie Prévot-Guéguiniat, Guillaume Lereaux, Florence Boirre, Ludwig Baux, Safa Ben Hassine, Jie Qiu, Xiaoming Huang, Jinzhu Xu, Sébastien Grégoire, Shosuke Ito, Kazumasa Wakamatsu, Xavier Marat
Research on new ingredients that can prevent excessive melanin production in the skin while considering efficacy, safety but also environmental impact is of great importance to significantly improve the profile of existing actives on the market and avoid undesirable side effects. Here, the discovery of an innovative technology for the management of hyperpigmentation is described. High-throughput screening tests on a wide chemical diversity of molecules and in silico predictive methodologies were essential to design an original thiopyridinone backbone and select 2-mercaptonicotinoyl glycine (2-MNG) as exhibiting the most favorable balance between the impact on water footprint, skin penetration potential and performance...
April 1, 2024: Pigment Cell & Melanoma Research
https://read.qxmd.com/read/38509752/characterization-of-prame-immunohistochemistry-reveals-lower-expression-in-pediatric-melanoma-compared-to-adult-melanoma
#4
JOURNAL ARTICLE
Stephan Forchhammer, Valentin Aebischer, Daniela Lenders, Christian M Seitz, Christopher Schroeder, Alexandra Liebmann, Michael Abele, Hannah Wild, Ewa Bien, Malgorzata Krawczyk, Dominik T Schneider, Ines B Brecht, Lukas Flatz, Matthias Hahn
Pediatric melanomas are rare tumors that have clinical and histological differences from adult melanomas. In adult melanoma, the immunohistochemical marker PRAME is increasingly employed as a diagnostic adjunct. PRAME is also under investigation as a target structure for next-generation immunotherapies including T-cell engagers. Little is known about the characteristics of PRAME expression in pediatric melanoma. In this retrospective study, samples from 25 pediatric melanomas were compared with control groups of melanomas in young adults (18-30 years; n = 32), adult melanoma (>30 years, n = 30), and benign melanocytic nevi in children (0-18 years; n = 30) with regard to the immunohistochemical expression of PRAME (diffuse PRAME expression >75%/absolute expression)...
March 20, 2024: Pigment Cell & Melanoma Research
https://read.qxmd.com/read/38445351/the-metabolism-of-melanin-synthesis-from-melanocytes-to-melanoma
#5
REVIEW
Marelize Snyman, Rachel Elizabeth Walsdorf, Sophia Nicole Wix, Jennifer Gibson Gill
Melanin synthesis involves the successful coordination of metabolic pathways across multiple intracellular compartments including the melanosome, mitochondria, ER/Golgi, and cytoplasm. While pigment production offers a communal protection from UV damage, the process also requires anabolic and redox demands that must be carefully managed by melanocytes. In this report we provide an updated review on melanin metabolism, including recent data leveraging new techniques, and technologies in the field of metabolism...
March 6, 2024: Pigment Cell & Melanoma Research
https://read.qxmd.com/read/38439523/genetic-insights-into-tietz-albinism-deafness-syndrome-a-new-dominant-negative-mutation-in-mitf
#6
JOURNAL ARTICLE
Kohei Yamamoto, Ken Okamura, Kazumasa Wakamatsu, Shosuke Ito, Kozue Akabane, Yosuke Arai, Junnosuke Kawaguchi, Yutaka Hozumi, Tamio Suzuki
Tietz albinism-deafness syndrome (TADS) is a rare and severe manifestation of Waardenburg syndrome that is primarily linked to mutations in MITF. In this report, we present a case of TADS resulting from a novel c.637G>C mutation in MITF (p.Glu213Gln; GenBank Accession number: NM_000248). A 3-year-old girl presented with congenital generalized hypopigmentation of the hair, skin, and irides along with complete sensorineural hearing loss. Histopathological and electron microscopy investigations indicated that this variant did not alter the number of melanocytes in the skin but significantly impaired melanosome maturation within melanocytes...
March 4, 2024: Pigment Cell & Melanoma Research
https://read.qxmd.com/read/38439216/topical-antibiotics-limit-depigmentation-in-a-mouse-model-of%C3%A2-vitiligo
#7
JOURNAL ARTICLE
Ahmed Ahmed Touni, Rachel Sohn, Cormac Cosgrove, Rohan S Shivde, Emilia R Dellacecca, Rasha T A Abdel-Aziz, Kettil Cedercreutz, Stefan J Green, Hossam Abdel-Wahab, I Caroline Le Poole
Oral neomycin administration impacts the gut microbiome and delays vitiligo development in mice, and topical antibiotics may likewise allow the microbiome to preserve skin health and delay depigmentation. Here, we examined the effects of 6-week topical antibiotic treatment on vitiligo-prone pmel-1 mice. Bacitracin, Neosporin, or Vaseline were applied to one denuded flank, while the contralateral flank was treated with Vaseline in all mice. Ventral depigmentation was quantified weekly. We found that topical Neosporin treatment significantly reduced depigmentation and exhibited effects beyond the treated area, while Bacitracin ointment had no effect...
March 4, 2024: Pigment Cell & Melanoma Research
https://read.qxmd.com/read/38411373/emerging-therapeutic-strategies-for-metastatic-uveal-melanoma-targeting-driver-mutations
#8
REVIEW
Xiao-Lian Liu, Zhou Run-Hua, Jing-Xuan Pan, Zhi-Jie Li, Le Yu, Yi-Lei Li
Uveal melanoma (UM) is the most common primary malignant intraocular tumor in adults. Although primary UM can be effectively controlled, a significant proportion of cases (40% or more) eventually develop distant metastases, commonly in the liver. Metastatic UM remains a lethal disease with limited treatment options. The initiation of UM is typically attributed to activating mutations in GNAQ or GNA11. The elucidation of the downstream pathways such as PKC/MAPK, PI3K/AKT/mTOR, and Hippo-YAP have provided potential therapeutic targets...
February 27, 2024: Pigment Cell & Melanoma Research
https://read.qxmd.com/read/38361478/the-yucatan-miniature-swine-as-a-model-for-post-inflammatory-hyperpigmentation
#9
JOURNAL ARTICLE
Ying Wang, Emilee Herringshaw, R Rox Anderson, Joshua Tam
Post-inflammatory hyperpigmentation (PIH) is a hypermelanosis that often occurs secondary to skin irritation or injury, especially in darker skin tones, for which there is currently a lack of effective treatment options. Few preclinical models are available to study PIH. Here, we show that the Yucatan miniature pig consistently develops PIH after skin injuries. Skin wounds were produced on Yucatan pigs by needle punches, full-thickness excisions, or burns. Wound sites were monitored and photographed regularly...
February 16, 2024: Pigment Cell & Melanoma Research
https://read.qxmd.com/read/38361107/review-are-moles-senescent
#10
REVIEW
Dorothy C Bennett
Melanocytic nevi (skin moles) have been regarded as a valuable example of cell senescence occurring in vivo. However, a study of induced nevi in a mouse model reported that the nevi were arrested by cell interactions rather than a cell-autonomous process like senescence, and that size distributions of cell nests within nevi could not be accounted for by a stochastic model of oncogene-induced senescence. Moreover, others reported that some molecular markers used to identify cell senescence in human nevi are also found in melanoma cells-not senescent...
February 15, 2024: Pigment Cell & Melanoma Research
https://read.qxmd.com/read/38343115/vitiligo-non-responding-lesions-to-narrow-band-uvb-have-intriguing-cellular-and-molecular-abnormalities-that-may-prevent-epidermal-repigmentation
#11
JOURNAL ARTICLE
Nathaniel B Goldstein, Andrea Steel, Landon Tomb, Zachary Berk, Junxiao Hu, Velmurugan Balaya, Laura Hoaglin, Kavya Ganuthula, Meet Patel, Erica Mbika, William A Robinson, Dennis R Roop, David A Norris, Stanca A Birlea
We have discovered that human vitiligo patients treated with narrow-band UVB (NBUVB) demonstrated localized resistance to repigmentation in skin sites characterized by distinct cellular and molecular pathways. Using immunostaining studies, discovery-stage RNA-Seq analysis, and confirmatory in situ hybridization, we analyzed paired biopsies collected from vitiligo lesions that did not repigment after 6 months of NBUVB treatment (non-responding) and compared them with repigmented (responding) lesions from the same patient...
February 11, 2024: Pigment Cell & Melanoma Research
https://read.qxmd.com/read/38178654/molecular-skin-fluorescence-imaging-a-tool-for-evaluating-early-melanoma-development
#12
JOURNAL ARTICLE
Amit Shachaf, Kevin Manbeck, Guang Yang, Catherine Shachaf
A novel approach to melanoma diagnosis-in vivo molecular skin fluorescence imaging (mSFI)-was developed to identify premalignant changes in the form of tissue remodeling related to melanoma development in humans by imaging the proximal microenvironment of lesions. The method was tested using a fluorescent peptide (ORL-1) which binds to αvβ3 integrin, a molecule associated with invasive melanoma development. A cut off score of 7 was established, differentiating melanomas from nonmelanoma nevi with 100% sensitivity, and 95...
January 4, 2024: Pigment Cell & Melanoma Research
https://read.qxmd.com/read/38213075/the-20th-international-congress-of-the-society-for-melanoma-research
#13
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
January 2024: Pigment Cell & Melanoma Research
https://read.qxmd.com/read/38158521/small-extracellular-vesicle-based-human-melanocyte-and-melanoma-signature
#14
JOURNAL ARTICLE
Andrea Agüera-Lorente, Ainhoa Alonso-Pardavila, María Larrinaga, María Dolores Boyano, Esperanza González, Juan Manuel Falcón-Pérez, Aintzane Asumendi, Aintzane Apraiz
Intercellular communication is a cell-type and stimulus-dependent event driven not only by soluble factors but also by extracellular vesicles (EVs). EVs include vesicles of different size and origin that contain a myriad of molecules. Among them, small EVs (sEV; <200 nm) have been shown to modulate not just regional cell responses but also distant organ behavior. In cancer, distant organ modulation by sEVs has been associated to disease dissemination, which is one of the main concerns in melanoma...
December 29, 2023: Pigment Cell & Melanoma Research
https://read.qxmd.com/read/38158377/comprehensive-molecular-findings-in-primary-malignant-melanoma-of-the-esophagus-a-multicenter-study
#15
JOURNAL ARTICLE
Ling Deng, Hai-Yun Wang, Chun-Fang Hu, Xiao-Yun Liu, Kuntai Jiang, Juan-Juan Yong, Xiao-Yan Wu, Kai-Hua Guo, Fang Wang
Primary malignant melanoma of the esophagus (PMME) is an extremely rare but highly aggressive malignancy with a poor prognosis. Due to the scarcity of driver gene alterations, there is a need for more clinical data to comprehensively depict its molecular alterations. This study reviewed 26 PMME cases from three medical centers. Hybrid capture-based targeted sequencing of 295 and 1021 genes was performed in 14 and 12 cases, respectively. We found that PMME patients had a relatively low tumor mutation burden (median, 2...
December 29, 2023: Pigment Cell & Melanoma Research
https://read.qxmd.com/read/38158376/the-role-of-dacarbazine-and-temozolomide-therapy-after-treatment-with-immune-checkpoint-inhibitors-in-malignant-melanoma-patients-a-case-series-and-meta-analysis
#16
JOURNAL ARTICLE
Viktoria Rydén, Ali Inan El-Naggar, Anthoula Koliadi, Cecilia Olsson Ladjevardi, Evangelos Digkas, Antonios Valachis, Gustav J Ullenhag
Dacarbazine (DTIC) and its oral counterpart temozolomide (TMZ) have been the most used agents in advanced malignant melanoma (MM) patients and they are still used routinely. The preferred first line treatment, immune checkpoint inhibitors (CPIs) might shape the tumor and the tumor microenvironment, possibly affecting the response to subsequent therapies. The aim of this study was to investigate the treatment effect of DTIC/TMZ in MM patients after CPI therapy in a consecutive patient cohort and through systematic literature review and meta-analysis...
December 29, 2023: Pigment Cell & Melanoma Research
https://read.qxmd.com/read/38153178/clinical-histological-and-molecular-differences-in-melanoma-due-to-different-tert-promoter-mutations-subtypes-a-retrospective-cross-sectional-study-in-684-melanoma-patients
#17
JOURNAL ARTICLE
Esperanza Manrique-Silva, Millán-Esteban David, Aguerralde-Martin Maider, Zaida García-Casado, Ruggero Moro, Celia Requena, Victor Través, Amaya Virós, Rajiv Kumar, Eduardo Nagore
Differences in survival according to the pTERT mutation subtypes (-124C > T, -146C > T, and tandem -138_139CC > TT) have been observed. The present study aimed to describe the clinical as the histopathological and molecular cutaneous melanoma features according to the presence of the three most prevalent pTERT mutation subtypes (-124C > T, -146C > T, and tandem -138_139CC > TT). A retrospective cross-sectional study including 684 patients was designed, and a Partial Least-Squares Discriminant Analysis (PLS-DA) was performed...
December 28, 2023: Pigment Cell & Melanoma Research
https://read.qxmd.com/read/38063139/overview-of-current-melanoma-therapies
#18
REVIEW
Anna Fateeva, Kevinn Eddy, Suzie Chen
Melanoma is the most aggressive type of skin cancer and is responsible for the majority of deaths from skin cancer. Therapeutic advances in the last few decades, notably the development of novel targeted therapies and immunotherapies have significantly improved patient outcomes; nonetheless, these options remain limited due to the onset of resistance to treatment modalities and relapse. In this review, we focus on the available therapeutic options, their benefits, and limitations.
December 8, 2023: Pigment Cell & Melanoma Research
https://read.qxmd.com/read/38013393/risk-factors-for-sentinel-lymph-node-metastasis-in-korean-acral-and-non-acral-melanoma-patients
#19
JOURNAL ARTICLE
Jee Yong Song, Young Jae Ryu, Ho Kyun Lee, Dong Hoon Lee, Yoo Duk Choi, Hyun Jeong Shim, Sook Jung Yun
Breslow thickness, ulceration, and mitotic rate are well-known prognostic factors for sentinel lymph node (SLN) metastasis in cutaneous melanoma. We investigated risk factors, including especially the degree of pigmentation, for SLN metastasis in Korean melanoma patients. We enrolled 158, composed of Korean 107 acral and 51 non-acral melanoma patients who underwent SLN biopsy. Clinicopathologic features such as Breslow thickness, ulceration, mitotic rate, and the degree of pigmentation were evaluated. The recurrence-free survival (RFS) rate and date of recurrence were determined...
November 27, 2023: Pigment Cell & Melanoma Research
https://read.qxmd.com/read/38010612/myron-gordon-award-lecture-2023-painting-the-neural-crest-how-studying-pigment-cells-illuminates-neural-crest-cell-biology
#20
REVIEW
Robert N Kelsh
It has been 30 (!!) years since I began working on zebrafish pigment cells, as a postdoc in the laboratory of Prof. Christiane Nüsslein-Volhard. There, I participated in the first large-scale mutagenesis screen in zebrafish, focusing on pigment cell mutant phenotypes. The isolation of colourless, shady, parade and choker mutants allowed us (as a postdoc in Prof. Judith Eisen's laboratory, and then in my own laboratory at the University of Bath since 1997) to pursue my ambition to address long-standing problems in the neural crest field...
November 27, 2023: Pigment Cell & Melanoma Research
journal
journal
41776
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.